Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2024	Mar. 31, 2024
ASSETS
Cash and cash equivalents	$ 8,284	$ 8,570
Restricted cash and cash equivalents	2,306	2,251
Investments in marketable securities	4,687	4,505
Finance receivables, net of allowance for credit losses of $1,646 and $1,637, respectively	103,771	101,669
Investments in operating leases, net	29,679	28,013
Other assets	5,330	4,373
Total assets	154,057	149,381
LIABILITIES AND SHAREHOLDER'S EQUITY
Debt	125,328	122,420
Deferred income taxes	3,340	3,272
Other liabilities	7,194	6,707
Total liabilities	135,862	132,399
Commitments and contingencies (Refer to Note 9)
Shareholder's equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at December 31, 2024 and March 31, 2024	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive loss	(67)	(65)
Retained earnings	17,345	16,130
Total shareholder's equity	18,195	16,982
Total liabilities and shareholder's equity	$ 154,057	$ 149,381